CoChat

Intranasal Glucagon: A Promising Approach for Treatment of Severe Hypoglycemia

Open access
Pontiroli, Antonio E. · 2015 · Journal of Diabetes Science and Technology
Cited by 39

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Prevention of diabetic complications is mainly obtained through optimal control of blood glucose levels. With hypoglycemic drugs like beta-cell stimulating drugs and especially insulin, the limit to treatment is represented by hypoglycemia, a life-threatening occurrence that is dangerous itself and can induce fear of other episodes. Glucagon, injected subcutaneously (SC) or intramuscularly (IM), is the treatment of choice for severe hypoglycemia outside of the hospital setting. However, due to practical aspects such as preparation of solutions for administration and injection by untrained persons, there are obstacles to its routine use. This review focuses on the current status of alternative routes of administration of peptide hormones, and in particular the intranasal (IN) route of glucagon, as a promising approach for the treatment of severe hypoglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1932296814557518

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 35

  1. 10.1210/jc.2012-1561 · DOI · Paper page
  2. 10.2165/00003088-198917050-00001 · DOI
  3. 10.1136/bmj.284.6312.303 · DOI
  4. 10.1016/S0169-409X(97)00062-8 · DOI
  5. Reynolds JEF, 1996, The Extra Pharmacopoeia
  6. 10.1023/A:1018997625726 · DOI
  7. 10.1023/A:1018992716621 · doi:10.1023/a:1018992716621
  8. 10.1016/S8756-3282(95)00262-6 · DOI
  9. 10.2337/dc13-0690 · DOI
  10. 10.1016/j.jconrel.2010.08.004 · DOI
  11. 10.1016/j.peptides.2008.09.026 · DOI
  12. 10.1016/j.ijpharm.2009.07.022 · DOI
  13. 10.1016/j.ijpharm.2009.12.060 · doi:10.1016/j.ijpharm.2009.12.060
  14. 10.1111/j.1749-6632.2010.05799.x · DOI · Paper page
  15. 10.2337/db10-1360 · DOI · Paper page
  16. 10.1124/jpet.103.063222 · DOI
  17. 10.1002/pdi.138 · DOI · Paper page
  18. 10.1002/pdi.1960140204 · DOI
  19. 10.1136/bmj.287.6390.462-a · DOI
  20. 10.1007/BF02590783 · DOI
  21. 10.1007/BF00558516 · DOI
  22. 10.1007/BF00400568 · DOI
  23. 10.1016/S0378-5173(01)00930-9 · DOI
  24. 10.2337/diacare.12.9.604 · DOI
  25. 10.1007/BF00401209 · DOI
  26. 10.1016/0168-8227(92)90042-P · DOI
  27. 10.1007/BF02374475 · DOI
  28. 10.1007/BF00195909 · DOI
  29. 10.1111/j.1365-2125.1992.tb05660.x · DOI
  30. 10.1016/j.molmet.2014.01.006 · DOI
  31. Riber D, 2013, Diabetes, 62, 404-P
  32. Newswanger B, 2013, Diabetes, 62, 402-P
  33. 10.1089/dia.2014.0047 · DOI
  34. 10.3109/10903127.2012.717171 · DOI
  35. Sicard E, A single site, randomized, four-way, four-period PK/PD crossover phase I clinical study in 16 fasted healthy adult volunteers receiving 3 dose levels of intranasally administered glucagon and one dose level of glucagon administered by subcutaneous injection

Cited by

See all 39

Metadata

Authors
Pontiroli, A. E.
Venue
Journal of Diabetes Science and Technology
Published
2014-11-10
Volume
9
Issue
1
Pages
38-43
ISSN
1932-2968 (ISSN-L)
OpenAlex
W1978425428
Cited by
39
References
4
FWCI
1.20
Type
journal article
Language
en
Open access
bronze
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intranasal Glucagon: A Promising Approach for Treatment of Severe Hypoglycemia. https://app.cochat.ai/papers/10.1177/1932296814557518
The paper
Pontiroli, A. E. (2015). Intranasal Glucagon: A Promising Approach for Treatment of Severe Hypoglycemia. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296814557518

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.